Stifel Financial Corp Sells 1,937 Shares of Doximity, Inc. (NASDAQ:DOCS)

Stifel Financial Corp decreased its position in Doximity, Inc. (NASDAQ:DOCS) by 3.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 49,674 shares of the company’s stock after selling 1,937 shares during the quarter. Stifel Financial Corp’s holdings in Doximity were worth $2,164,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of DOCS. Morse Asset Management Inc purchased a new position in Doximity during the third quarter valued at $46,000. Integrated Wealth Concepts LLC purchased a new position in shares of Doximity in the 3rd quarter worth about $308,000. Comprehensive Financial Management LLC bought a new position in Doximity in the 3rd quarter worth about $7,704,000. Point72 Hong Kong Ltd bought a new position in Doximity in the 3rd quarter worth about $137,000. Finally, Verition Fund Management LLC increased its position in shares of Doximity by 7.8% during the third quarter. Verition Fund Management LLC now owns 42,812 shares of the company’s stock valued at $1,865,000 after acquiring an additional 3,088 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors.

Doximity Stock Up 5.7 %

Shares of Doximity stock opened at $55.18 on Friday. The firm has a market cap of $10.30 billion, a price-to-earnings ratio of 63.43, a PEG ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $61.75. The business has a 50-day moving average price of $48.82 and a 200-day moving average price of $38.57.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Wells Fargo & Company upgraded Doximity from an “underweight” rating to an “equal weight” rating and lifted their price objective for the stock from $19.00 to $41.00 in a report on Friday, November 8th. Barclays increased their price objective on shares of Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research note on Monday, November 11th. KeyCorp raised shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 target price for the company in a report on Friday, November 8th. Morgan Stanley raised shares of Doximity from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $33.00 to $53.00 in a research report on Thursday, November 14th. Finally, Evercore ISI lifted their target price on Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Twelve investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $52.44.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.